VPS-II
2003
Second Vasovagal Pacemaker Study
In 100 patients with recurrent severe vasovagal syncope who all received a dual-chamber pacemaker, active dual-chamber pacing did not significantly reduce recurrence of syncope within 6 months compared with the pacemaker programmed to sensing only.
Result
- Absolute difference
- 9 points
relative risk reduction3095% CI -33 to 63 · P = 0.14
The absolute difference is derived from the event rates.
Also reported: Complications included 7 lead dislodgements, 1 tamponade and 1 generator infection.
- Subtopic
- Pacing for reflex syncope
- Design
- Double-blind RCT (pacing on vs sensing only)
- Relevance
- Supporting: context rather than must-know.
- Source
- Connolly SJ, Sheldon R, Thorpe KE, et al. JAMA. 2003;289(17):2224-2229.doi 10.1001/jama.289.17.2224
Discussion & critique
Underpowered and short, and it enrolled tilt-positive patients without documented spontaneous asystole, so a real effect in the truly cardioinhibitory subgroup could have been missed. Its enduring value is methodological: by implanting every patient and randomising only the programming, it showed the benefit reported by earlier unblinded pacing trials was largely a placebo effect of surgery.